The board of Alembic Pharmaceuticals has approved a proposal to raise up to ₹300 crore through non-convertible debentures on private placement basis.
from Business Line - Markets https://ift.tt/2Mk4ugV
Tuesday, September 11, 2018
Subscribe to:
Post Comments (Atom)
HELLO MY NAME IS VIPUL SONI IM CREAT THIS BLOG PLEASE REGULAR COMMENT THIS BLOG.
No comments:
Post a Comment